-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
A few days ago, the official website of CDE showed that the dabigatran etexilate capsules of Zhejiang Huahai Pharmaceutical Co.
Dabigatran etexilate is a prodrug of dabigatran, which is a non-peptide thrombin inhibitor.
Sales of dabigatran etexilate capsules in Chinese public medical institutions and physical pharmacies in Chinese cities (unit: 100 million yuan)
Source: Mi Nei Net Database
Dabigatran etexilate was developed by Boehringer Ingelheim.
Source: One-click search on Mi Nei.
Currently, there are 5 manufacturers of dabigatran etexilate capsules
Source: Meinenet MED2.
In addition, six other companies have submitted applications for the product and are under review and approval.
Source: CDE official website, Minet.